Author: Carl Genberg
-
N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope
CeraShield™ resorbable envelope targets prevention of bacterial and highly lethal fungal infections and reduction of surgical site infections of pacemaker implantations
-
Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat
New Publication regarding Ceragenin CSA-131’s Potent Efficacy against fungal pathogen Candida auris, a New Serious Global Health Threat
-
N8 Medical Announces Compelling Publication Supporting Its Breakthrough CeraShield™ Endotracheal Tube
CeraShield™ Coating Prevents Bacterial and Fungal Colonization, and Reduces Endotoxin
-
FDA Grants N8 Medical Breakthrough Device Designation
FDA Grants N8 Medical’s Request for Breakthrough Device Designation for its CeraShield™ Endotracheal Tube
-
New Research Shows CSA-131 has Potent Antifungal Activity
A recent published study by Professor Robert Bucki and colleagues has shown that CSA-131 has broad spectrum antifungal activity and retains activity in various body fluids.
